About this trial

The purpose of this study is to elucidate the mechanisms underlying eosinophil growth, survival, migration, and function and to investigate and further characterize the pathophysiology of, clinical manifestations of, and spectrum of disease severity of eosinophilic inflammation in humans.

Eligibility criteria

Qualifiers

Signed informed consent obtained from the patient or parent/guardian. Assent will be obtained from all minors 11 years of age and older.

Carrying a diagnosis of eosinophilic gastrointestinal disease, eosinophilic inflammatory disease, or food allergy OR family member, or normal control

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

1
Cincinnati Children's Hospital Medical Center45229-3039, CincinnatiOhio, United States

Sponsors and collaborators

Children's Hospital Medical Center, Cincinnati

Lead sponsor